CNBC's Jim Cramer on Friday walked investors through an earnings-heavy week, highlighting reports from Amazon, Alphabet, Eli ...

As more United States drug price changes have come to light this month, it remains clear that companies are tamping down ...

President Donald Trump is executing a shock and awe strategy, burying the public in a smoky cloud of flamboyant proposals.

Stocks swiftly recovered from the DeepSeek-driven sell-off early in the week but came under pressure on Friday amid concerns ...

The 1970s and early 1980s were challenging due to high inflation, stagflation ... by 150 percentage points (see more details here). Eli Lilly and Company (NYSE:LLY) develops and markets human ...

President Donald Trump’s Medicare agency is seeking to bring more transparency to the US government’s drug price negotiation ...

After a dramatic week of AI stock swings and major tech earnings, it’s time for another round of tech results. Despite cooling inflation, the Fed has stayed quiet on potential rate cuts. That puts ...

Drugmakers hope to see efforts that focus more on cracking down on pharmacy benefit managers while promoting drug innovation ...

The IRA measure is a good first step, but some are looking even further ahead to GLP-1 price drops to increase access.

President Donald Trump is executing a shock and awe strategy, burying the public in a smoky cloud of flamboyant proposals.

We recently compiled a list of the 12 Best Long Term Low Risk Stocks to Buy Right Now. In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY) stands against the other ...

We recently compiled a list of the 12 Best Big Name Stocks to Invest in Now. In this article, we are going to take a look at ...